Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical ...

UK Prime Minister Andy Burnham, who lost his father to Alzheimer's disease last week, has been urged to implement a ...

Iambic Therapeutics, which specialises in applying AI to drug discovery and development, has filed for an IPO on the Nasdaq, shortly after adding AbbVie to its roster of pharma pa ...

An adjuvanted, trivalent influenza vaccine developed by CSL Seqirus and recently approved in the UK, Aujemflu, will be deployed ahead of the 2027/28 flu season under an agreement with the government.

A consumer advocacy group has scrutinised some of the Most Favoured Nation (MFN) pricing deals the Trump administration has ...

ADARx Pharmaceuticals, a San Diego-based biotech developing siRNA therapies for various diseases, has announced the terms for ...

Beacon Therapeutics is preparing to file for approval of its gene therapy for eye disorder X-linked retinitis pigmentosa ...

Facing considerable pressure in its diabetes and obesity franchises, Novo has revealed a plan to launch five or more ...

Adding ITM will also give Telix a pipeline of follow-up radiopharma candidates, including clinical-stage diagnostics and ...

The recommendation by the CHMP sets up an EU approval in the coming weeks for Klygefa (gefurulimab), a dual-binding nanobody ...

Eli Lilly's oral selective oestrogen receptor degrader (SERD) imlunestrant (Inluriyo), has received a second FDA approval, this time in combination with CDK4/6 inhibitor abemaciclib (Verzenio), ...

Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for the UK’s ...